Filing Analysis
GoHealth, Inc. has received a notice from Nasdaq that its Class A common stock will be delisted, with trading suspended effective June 16, 2026. This action follows the company's voluntary filing for Chapter 11 bankruptcy on June 7, 2026, and a prior failure to meet minimum market value requirements.
🚩 Red Flags
- Bankruptcy: Company is currently in Chapter 11 proceedings.
- Delisting: Immediate removal from Nasdaq with no intent to appeal.
- Equity Wipeout Risk: Filing explicitly mentions the potential 'cancellation of the Company’s and GoHealth Holdings’ existing equity interests' under the Plan.
- Market Value Deficiency: Failed to maintain the $35 million minimum market value requirement since March 2026.
- Going Concern: Forward-looking statements explicitly reference the 'ability to continue as a going concern'.
📋 Key Facts
- Nasdaq notified the company on June 9, 2026, of the decision to delist GOCO.
- Trading suspension is scheduled for the opening of business on June 16, 2026.
- The company filed for Chapter 11 bankruptcy on June 7, 2026, to implement a prepackaged reorganization plan.
- Nasdaq cited three primary reasons for delisting: the Chapter 11 filing, concerns over residual equity interest, and inability to sustain listing compliance.
- The company was previously notified on March 18, 2026, that it failed to meet the minimum market value requirement of $35 million (Rule 5550(b)(2)).
- The company does not intend to appeal the delisting determination.
GoHealth, Inc. and its subsidiaries filed voluntary petitions for Chapter 11 bankruptcy on June 7, 2026, to implement a prepackaged plan of reorganization. The filing triggers defaults on multiple material debt agreements and is expected to result in the delisting of Class A common stock from Nasdaq.
🚩 Red Flags
- Bankruptcy filing (Chapter 11).
- Cancellation of existing equity interests (common stock holders likely to be wiped out).
- Imminent Nasdaq delisting.
- Acceleration of debt obligations under material credit agreements.
- Multiple 8-K items in a single filing (1.03, 2.04, 5.02, 7.01).
- Significant executive payout: CEO Vijay Kotte received ~$2.87 million as part of a new Cash Performance Plan coinciding with the bankruptcy filing.
📋 Key Facts
- Filed for Chapter 11 bankruptcy in the District of Delaware on June 7, 2026.
- Existing equity interests, including Class A and B common stock, will be canceled upon the Effective Date.
- A $10.0 million cash equity recovery pool is planned for eligible Class A common stock and GoHealth Holdings unit holders.
- The company expects an immediate suspension of trading and a delisting notice from Nasdaq.
- The bankruptcy triggers defaults on the Superpriority Senior Secured Credit Agreement (Aug 6, 2025) and a 2019 Credit Agreement.
- The annual stockholders' meeting scheduled for June 17, 2026, has been cancelled.
GoHealth, Inc. announced its financial results for the fiscal year ended December 31, 2025, via a press release issued on March 31, 2026. The filing is a routine disclosure of annual operational performance and financial condition.
📋 Key Facts
- Financial results cover the twelve months ended December 31, 2025.
- The press release was furnished as Exhibit 99.1 under Item 2.02.
- The report was signed by Brendan Shanahan, Chief Financial Officer, on March 31, 2026.
GoHealth, Inc. received a deficiency notice from Nasdaq on March 18, 2026, for failing to maintain the minimum market value of listed securities (MVLS) of $35 million. The company also failed to meet alternative listing requirements related to stockholders' equity and net income, and has 180 days to regain compliance.
🚩 Red Flags
- Market value has dropped below the $35 million threshold.
- Failure to meet multiple alternative listing criteria (equity and net income), indicating broader financial weakness.
- Risk of delisting if market valuation does not recover by September 2026.
📋 Key Facts
- Notice received from Nasdaq Listing Qualifications Department on March 18, 2026.
- Non-compliance with Nasdaq Listing Rule 5550(b)(2) requiring a minimum MVLS of $35 million.
- Company also fails alternative standards under Rules 5550(b)(1) (stockholders' equity of $2.5 million) and 5550(b)(3) (net income of $500,000).
- Compliance period of 180 calendar days granted, expiring on September 14, 2026.
- To regain compliance, MVLS must close at $35 million or more for at least 10 consecutive business days.